Skip to content
Good Vibes Only - The Smoking Chair - Motivation
  • Food & Drink
  • News & Opinion
  • Sports & Entertainment
  • Travel & Leisure
  • 👕 Merch 👕
  • Food & Drink
  • News & Opinion
  • Sports & Entertainment
  • Travel & Leisure
  • 👕 Merch 👕
Facebook Instagram Threads Patreon
Facebook Instagram Threads Patreon
Good Vibes Only - The Smoking Chair - Motivation
  • Food & Drink
  • News & Opinion
  • Sports & Entertainment
  • Travel & Leisure
  • 👕 Merch 👕
  • Food & Drink
  • News & Opinion
  • Sports & Entertainment
  • Travel & Leisure
  • 👕 Merch 👕
Final Trades Alphabet Visa Cummins & more

Final Trades: Alphabet, Visa, Cummins & more

October 25, 2023

The “Halftime Report” traders give their top picks to watch for the second half.

Final Trades: HACK, C, QQQ & UNH

Final Trades: HACK, C, QQQ & UNH

October 14, 2023

The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.

Jim Cramer takes a closer look at stock market effects from diabetic and weight-loss drugs

Jim Cramer takes a closer look at stock market effects from diabetic and weight-loss drugs

October 13, 2023

‘Mad Money’ host Jim Cramer takes a deep dive into obesity drugs impact on various sectors.

CNBC - Jim Cramer - Lightning Round

Lightning Round: Impinj is a great company, not a great stock

February 21, 2023

#PI #ASTS #WOOF #ZI #PFE

Ryan Reynolds and Mark Douglas win CNBC stock draft

Ryan Reynolds and Mark Douglas win CNBC stock draft

February 14, 2023

Mark Douglas and Ryan Reynolds joins ‘Power Lunch’ to discuss their CNBC stock draft win, the strategies behind their picks and Mint Mobile takeover rumors.

CNBC - Halftime Report - Final Trades

Final Trades: Uber, Citi & Wabtec

February 8, 2023

#UBER #C #Wabtec

CNBC - Jim Cramer - Lightning Round

Cramer’s lightning round: I like Nucor over Cleveland-Cliffs

January 25, 2023

#OGN #BABA #CLF #GOLD #BOWL #JCI | Cramer answered callers’ investing questions at rapid speed on Wednesday. | 2023-01-25

CNBC - Jim Cramer - Lightning Round

Cramer’s lightning round: Amicus Therapeutics is an ideal spec

January 24, 2023

Cramer answered callers’ investing questions at rapid speed on Tuesday. | 2023-01-24

Copyright © 2026 | Privacy Policy | Terms & Conditions | Cookies Policy | Contact